STTK · Shattuck Labs, Inc. · Documents

$4.62 +0.13 (+2.90%) At close · Nov 6 Q3 2023 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$470.51M

101.84M

Volume · Nov 6 1.15M Avg daily vol (3M) 1.14M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $1M down 82.5% 10-K filed Mar 5, 2026 Quarterly report New FY2026 Q3 Revenue $0 10-Q filed Nov 5, 2026 Latest results New Financial results 8-K filed Nov 5, 2026 Earnings call Q3 2023 earnings call Held Nov 9, 2023

2026

Nov 5

Quarterly report 10-Q FY2026 Q3, ended Sep 30

Quarterly report for FY2026 Q3 AI summary on its way

Revenue $0 Net loss $25.2M Diluted EPS -$0.14

Nov 5

Current report 8-K

Financial results AI summary on its way

Sep 8

Investor event

Wells Fargo 21st Annual Healthcare Conference AI summary on its way

Aug 11

Current report 8-K

Financial results AI summary on its way

Aug 11

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Revenue $0 Net loss $15.15M Diluted EPS -$0.12

Jun 11

Current report 8-K Events of Jun 9

Entered into a material agreement AI summary on its way

Jun 9

Current report 8-K Events of Jun 8

Regulation FD disclosure, Other events AI summary on its way

Jun 2

Current report 8-K Events of May 28

Director or officer change, or executive pay, Shareholder vote results AI summary on its way

May 7

Quarterly report 10-Q FY2026 Q1, ended Mar 31

Quarterly report for FY2026 Q1 AI summary on its way

Revenue $0 Net loss $14.77M Diluted EPS -$0.13

May 7

Current report 8-K

Financial results AI summary on its way

Apr 8

Proxy statement DEF 14A Meeting May 28, 2026

Proxy statement AI summary on its way

Apr 8

Annual report to holders ARS

Annual report to holders AI summary on its way

Apr 8

Proxy statement DEFA14A

Proxy statement AI summary on its way

Mar 5

Current report 8-K

Financial results AI summary on its way

Mar 5

Annual report 10-K FY2025, ended Dec 31

Annual report for FY2025 AI summary on its way

Revenue $1M ▼ 82.5% Net loss $48.81M Diluted EPS -$0.70

Feb 5

Current report 8-K

Other events AI summary on its way

Jan 22

Current report 8-K

Entered into a material agreement AI summary on its way

Jan 13

Registration statement S-3

Registration statement AI summary on its way

2025

Nov 6

Current report 8-K/A

Financial results

Nov 6

Current report 8-K

Financial results

Nov 6

Quarterly report 10-Q FY2025 Q3, ended Sep 30

Quarterly report for FY2025 Q3

Revenue $1M ▼ 66.6% Net loss $10.06M Diluted EPS -$0.14

Sep 18

Registration statement S-3

Registration statement

Aug 26

Current report 8-K Events of Aug 25

Director or officer change, or executive pay, Regulation FD disclosure

Aug 14

Current report 8-K

Financial results

Aug 14

Quarterly report 10-Q FY2025 Q2, ended Jun 30

Quarterly report for FY2025 Q2

Revenue $0 Net loss $12.46M Diluted EPS -$0.24

Aug 5

Current report 8-K Events of Aug 4

Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure

Jul 15

Current report 8-K Events of Jul 10

Shareholder vote results

May 21

Proxy statement DEF 14A Meeting Jul 10, 2025

Proxy statement

May 21

Annual report to holders ARS

Annual report to holders

May 21

Proxy statement DEFA14A

Proxy statement

May 1

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2024

May 1

Current report 8-K

Financial results

May 1

Quarterly report 10-Q FY2025 Q1, ended Mar 31

Quarterly report for FY2025 Q1

Revenue $0 Net loss $13.7M Diluted EPS -$0.27

Apr 30

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2024

Mar 27

Current report 8-K

Financial results

Mar 27

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $5.72M ▲ 245.3% Net loss $75.41M Diluted EPS -$1.49

2024

Nov 14

Current report 8-K

Financial results

Nov 14

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $3M ▲ 336.9% Net loss $16.68M Diluted EPS -$0.33

Oct 1

Current report 8-K Events of Sep 30

Ended a material agreement, Exit or restructuring costs, Other events

Aug 1

Current report 8-K

Financial results

Aug 1

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $1.61M ▲ 704.5% Net loss $21.55M Diluted EPS -$0.42

Jun 14

Current report 8-K

Regulation FD disclosure

Jun 11

Current report 8-K/A Events of Mar 1

Director or officer change, or executive pay

Jun 10

Current report 8-K Events of Jun 7

Shareholder vote results

May 2

Current report 8-K

Financial results

May 2

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $1.12M ▲ 1856.1% Net loss $18.5M Diluted EPS -$0.37

Apr 23

Proxy statement DEF 14A Meeting Jun 7, 2024

Proxy statement

Apr 23

Annual report to holders ARS

Annual report to holders

Apr 23

Proxy statement DEFA14A

Proxy statement

Mar 4

Current report 8-K Events of Mar 1

Director or officer change, or executive pay, Regulation FD disclosure

Showing 1–50 of 107 documents

Key facts CIK 1680367 CUSIP 82024L103 13F (30d) 41 filings 29 filers Visit website Investor relations